Glenmark Pharmaceuticals reports 38% fall in Q2 consolidated net profit

15 Nov 2019 Evaluate

Glenmark Pharmaceuticals has reported results for second quarter ended September 30, 2019.

The company has reported a fall of 42.21% in its net profit at Rs 432.00 crore for the quarter under review as compared to Rs 747.56 crore for the same quarter in the previous year. However, total income of the company increased by 4.00% at Rs 1982.29 crore for Q2FY20 as compared Rs 1906.02 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 38.28% in its net profit at Rs 255.54 crore for the quarter under review as compared to Rs 414.00 crore for the same quarter in the previous year. However, total income of the company increased by 6.42% at Rs 2895.87 crore for Q2FY20 as compared Rs 2721.21 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

2000.60 -10.90 (-0.54%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×